Psychiatry Research: Neuroimaging
Volume 182, Issue 3 , Pages 251-260 , 30 June 2010

N-acetyl aspartate concentration in the anterior cingulate cortex in patients with schizophrenia: A study of clinical and neuropsychological correlates and preliminary exploration of cognitive behaviour therapy effects

  • Preethi Premkumar

      Affiliations

    • Department of Psychology, Institute of Psychiatry, King's College London, London, United Kingdom
    • ,
  • Vivek A. Parbhakar

      Affiliations

    • Department of Psychology, Institute of Psychiatry, King's College London, London, United Kingdom
    • ,
  • Dominic Fannon

      Affiliations

    • Department of Psychology, Institute of Psychiatry, King's College London, London, United Kingdom
    • Division of Psychological Medicine and Psychiatry, Institute of Psychiatry, King's College London, London, United Kingdom
    • ,
  • David Lythgoe

      Affiliations

    • Centre for Neuroimaging Sciences, Institute of Psychiatry, King's College London, London, United Kingdom
    • ,
  • Steven C. Williams

      Affiliations

    • Centre for Neuroimaging Sciences, Institute of Psychiatry, King's College London, London, United Kingdom
    • ,
  • Elizabeth Kuipers

      Affiliations

    • Department of Psychology, Institute of Psychiatry, King's College London, London, United Kingdom
    • NIHR Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust, London, London, United Kingdom
    • ,
  • Veena Kumari

      Affiliations

    • Department of Psychology, Institute of Psychiatry, King's College London, London, United Kingdom
    • Corresponding Author InformationCorresponding author. PO78, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, United Kingdom. Tel.: +44 207 848 0233; fax: +44 207 848 0860.

Received 15 October 2009 ,Revised 18 February 2010 ,Accepted 18 February 2010.

References 

  1. Adler CM, Malhotra AK, Elman I, Goldberg T, Egan M, Pickar D, et al. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. American Journal of Psychiatry. 1999;156:1646–1649
  2. Andres RH, Ducray AD, Schlattner U, Wallimann T, Widmer HR. Functions and effects of creatine in the central nervous system. Brain Research Bulletin. 2008;76:329–343
  3. Baiano M, David A, Versace A, Churchill R, Balestrieri M, Brambilla P. Anterior cingulate volumes in schizophrenia: a systematic review and a meta-analysis of MRI studies. Schizophrenia Research. 2007;93:1–12
  4. Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994;50:7–15
  5. Behrens TE, Woolrich MW, Walton ME, Rushworth MF. Learning the value of information in an uncertain world. Nature Neuroscience. 2007;10:1214–1221
  6. Bertolino A, Esposito G, Callicott JH, Mattay VS, Van Horn JD, Frank JA, et al. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. American Journal of Psychiatry. 2000;157:26–33
  7. Braus DF, Ende G, Weber-Fahr W, Demirakca T, Henn FA. Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study. Pharmacopsychiatry. 2001;34:251–253
  8. Braus DF, Ende G, Weber-Fahr W, Demirakca T, Tost H, Henn FA. Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia. European Neuropsychopharmacology. 2002;12:145–152
  9. Burgess PW, Shallice T. The Hayling and Brixton Tests. Bury St Edmunds: Thames Valley Test Company; 1997;
  10. Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, Coppola R, et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cerebral Cortex. 2000;10:1078–1092
  11. Carter CS, van Veen V. Anterior cingulate cortex and conflict detection: an update of theory and data. Cognitive, Affective and Behavioral Neuroscience. 2007;7:367–379
  12. Cornblatt BA, Risch JJ, Faris G, Friedman D, Erlenmeyer-Kimling L. The Continuous Performance Test, Identical Pairs Version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Research. 1988;26:223–238
  13. Costafreda SG, Khanna A, Mourao-Miranda J, Fu CH. Neural correlates of sad faces predict clinical remission to cognitive behavioural therapy in depression. NeuroReport. 2009;20:637–641
  14. Deicken RF, Zhou L, Schuff N, Weiner MW. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia. Schizophrenia Research. 1997;27:65–71
  15. Deicken RF, Johnson C, Pegues M. Proton magnetic resonance spectroscopy of the human brain in schizophrenia. Reviews in the Neurosciences. 2000;11:147–158
  16. Ende G, Braus DF, Walter S, Weber-Fahr W, Soher B, Maudsley AA, et al. Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophrenia Research. 2000;41:389–395
  17. Fannon D, Simmons A, Tennakoon L, O'Ceallaigh S, Sumich A, Doku V, et al. Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia. Biological Psychiatry. 2003;54:587–598
  18. Ferguson KJ, MacLullich AM, Marshall I, Deary IJ, Starr JM, Seckl JR, et al. Magnetic resonance spectroscopy and cognitive function in healthy elderly men. Brain. 2002;125:2743–2749
  19. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders—Patient Edition (SCID-I/P, 11/2002 revision). New York, NY: Biometrics Research Department; 2002;
  20. Fornito A, Yucel M, Dean B, Wood SJ, Pantelis C. Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophrenia Bulletin. 2008;35:973–993
  21. Fowler D, Garety PA, Kuipers E. Cognitive Behaviour Therapy for Psychosis: Theory and Practice. Chichester: Wiley; 1995;
  22. Fujimoto T, Takeuch K, Matsumoto T, Kamimura K, Hamada R, Nakamura K, et al. Abnormal glucose metabolism in the anterior cingulate cortex in patients with schizophrenia. Psychiatry Research. 2007;154:49–58
  23. Goff DC, Hennen J, Lyoo IK, Tsai G, Wald LL, Evins AE, et al. Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine. Biological Psychiatry. 2002;51:493–497
  24. Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR. Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Archives of General Psychiatry. 1997;54:159–165
  25. Heaton RK, Chelune GJ, Tally JL, Kay GG, Curtiss G. Wisconsin Card Sorting Test Manual: Revised and Expanded. Odessa, FL: Psychological Assessment Resources; 1993;
  26. Honea R, Crow TJ, Passingham D, Mackay CE. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. American Journal of Psychiatry. 2005;162:2233–2245
  27. Hughes C, Kumari V, Soni W, Das M, Binneman B, Drozd S, et al. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophrenia Research. 2003;59:137–146
  28. Jung RE, Brooks WM, Yeo RA, Chiulli SJ, Weers DC, Sibbitt WL. Biochemical markers of intelligence: a proton MR spectroscopy study of normal human brain. Proceedings. Biological Sciences. 1999;266:1375–1379
  29. Kaneda M, Osaka N. Role of anterior cingulate cortex during semantic coding in verbal working memory. Neuroscience Letters. 2008;436:57–61
  30. Kay SR, Fiszbein A, Opier LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 1987;13:261–276
  31. Kennerley SW, Dahmubed AF, Lara AH, Wallis JD. Neurons in the frontal lobe encode the value of multiple decision variables. Journal of Cognitive Neuroscience. 2008;21:1162–1178
  32. Kim J, Whyte J, Wang J, Rao H, Tang KZ, Detre JA. Continuous ASL perfusion fMRI investigation of higher cognition: quantification of tonic CBF changes during sustained attention and working memory tasks. Neuroimage. 2006;31:376–385
  33. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry. 1994;51:199–214
  34. Kumari V, Peters ER, Fannon D, Antonova E, Premkumar P, Anilkumar AP, et al. Dorsolateral prefrontal cortex activity predicts responsiveness to cognitive behaviour therapy in schizophrenia. Biological Psychiatry. 2009;66:594–602
  35. Lahti AC, Koffel B, LaPorte D, Tamminga CA. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology. 1995;13:9–19
  36. Lenartowicz A, McIntosh AR. The role of anterior cingulate cortex in working memory is shaped by functional connectivity. Journal of Cognitive Neuroscience. 2005;17:1026–1042
  37. Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, et al. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology. 1997;17:141–150
  38. McLean MA, Woermann FG, Barker GJ, Duncan JS. Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter. Magnetic Resonance in Medicine. 2000;44:401–411
  39. McMorris T, Harris RC, Swain J, Corbett J, Collard K, Dyson RJ, et al. Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol. Psychopharmacology (Berl). 2006;185:93–103
  40. McMorris T, Harris RC, Howard AN, Langridge G, Hall B, Corbett J, et al. Creatine supplementation, sleep deprivation, cortisol, melatonin and behavior. Physiology and Behaviour. 2007;90:21–28
  41. Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR in Biomedicine. 1991;4:47–52
  42. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron. 2003;40:881–884
  43. Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, et al. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. Journal of Psychiatric Research. 2007;41:625–634
  44. Ohrmann P, Kugel H, Bauer J, Siegmund A, Kolkebeck K, Suslow T, et al. Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy. Schizophrenia Research. 2008;106:156–163
  45. Ongur D, Prescot AP, Jensen JE, Cohen BM, Renshaw PF. Creatine abnormalities in schizophrenia and bipolar disorder. Psychiatry Research: Neuroimaging. 2009;172:44–48
  46. Osaka N, Osaka M, Kondo H, Morishita M, Fukuyama H, Shibasaki H. The neural basis of executive function in working memory: an fMRI study based on individual differences. Neuroimage. 2004;21:623–631
  47. Perry G, Nunomura A, Hirai K, Zhu X, Perez M, Avila J, et al. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?. Free Radical Biology and Medicine. 2002;33:1475–1479
  48. Peterson BS, Skudlarski P, Gatenby JC, Zhang H, Anderson AW, Gore JC. An fMRI study of Stroop word-color interference: evidence for cingulate subregions subserving multiple distributed attentional systems. Biological Psychiatry. 1999;45:1237–1258
  49. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine. 1993;30:672–679
  50. Rae C, Digney AL, McEwan SR, Bates TC. Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial. Proceedings. Biological Sciences. 2003;270:2147–2150
  51. Ross AJ, Sachdev PS. Magnetic resonance spectroscopy in cognitive research. Brain Research. Brain Research Reviews. 2004;44:83–102
  52. Rushworth MF, Walton ME, Kennerley SW, Bannerman DM. Action sets and decisions in the medial frontal cortex. Trends in Cogntive Sciences. 2004;8:410–417
  53. Rutten BP, Korr H, Steinbusch HW, Schmitz C. The aging brain: less neurons could be better. Mechanisms of Ageing and Development. 2003;124:349–355
  54. Sanches RF, Crippa JA, Hallak JE, de Sousa JP, Araujo D, Santos AC, et al. Proton magnetic resonance spectroscopy of the frontal, cingulate and perirolandic cortices and its relationship to skin conductance in patients with schizophrenia. Brazilian Journal of Medical and Biological Research. 2008;41:1132–1141
  55. Schlosser RG, Koch K, Wagner G, Nenadic I, Roebel M, Schachtzabel C, et al. Inefficient executive cognitive control in schizophrenia is preceded by altered functional activation during information encoding: an fMRI study. Neuropsychologia. 2008;46:336–347
  56. Shapiro AM, Benedict RH, Schretlen D, Brandt J. Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. The Clinical Neuropsychologist. 1999;13:348–358
  57. Smith EE, Jonides J. Storage and executive processes in the frontal lobes. Science. 1999;283:1657–1661
  58. Szoke A, Trandafir A, Dupont ME, Meary A, Schurhoff F, Leboyer M. Longitudinal studies of cognition in schizophrenia: meta-analysis. British Journal of Psychiatry. 2008;192:248–257
  59. Tayoshi S, Sumitani S, Taniguchi K, Shibuya-Tayoshi S, Numata S, Iga JI, et al. Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy ((1)H-MRS). Schizophrenia Research. 2009;108:69–77
  60. Theberge J, Bartha R, Drost DJ, Menon RS, Malla A, Takhar J, et al. Glutamate and glutamine measured with 4.0T proton MRS in never-treated patients with schizophrenia and healthy volunteers. American Journal of Psychiatry. 2002;159:1944–1946
  61. Theberge J, Al-Semaan Y, Williamson PC, Menon RS, Neufeld RW, Rajakumar N, et al. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. American Journal of Psychiatry. 2003;160:2231–2233
  62. Theberge J, Al-Semaan Y, Drost DJ, Malla AK, Neufeld RW, Bartha R, et al. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla. Psychiatry Research. 2004;131:107–114
  63. Tranberg M, Stridh MH, Guy Y, Jilderos B, Wigstrom H, Weber SG, et al. NMDA-receptor mediated efflux of N-acetylaspartate: physiological and/or pathological importance?. Neurochemistry International. 2004;45:1195–1204
  64. Tranberg M, Abbas AK, Sandberg M. In vitro studies on the putative function of N-acetylaspartate as an osmoregulator. Neurochemical Research. 2007;32:1248–1255
  65. Walton ME, Croxson PL, Behrens TE, Kennerley SW, Rushworth MF. Adaptive decision making and value in the anterior cingulate cortex. Neuroimage. 2007;36(Suppl 2):T142–T154
  66. Wechsler D. Wechsler Memory Scale—Revised. New York: Psychological Corporation; 1987;
  67. Weinberger DR, Aloia MS, Goldberg TE, Berman KF. The frontal lobes and schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences. 1994;6:419–427
  68. Wood SJ, Yucel M, Wellard RM, Harrison BJ, Clarke K, Fornito A, et al. Evidence for neuronal dysfunction in the anterior cingulate of patients with schizophrenia: a proton magnetic resonance spectroscopy study at 3T. Schizophrenia Research. 2007;94:328–331
  69. Yamasue H, Fukui T, Fukuda R, Yamada H, Yamasaki S, Kuroki N, et al. 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. NeuroReport. 2002;13:2133–2137
  70. Yeo RA, Hill D, Campbell R, Vigil J, Brooks WM. Developmental instability and working memory ability in children: a magnetic resonance spectroscopy investigation. Developmental Neuropsychology. 2000;17:143–159

PII: S0925-4927(10)00074-0

doi: 10.1016/j.pscychresns.2010.02.008

Psychiatry Research: Neuroimaging
Volume 182, Issue 3 , Pages 251-260 , 30 June 2010

Article Tools

* Image Usage & Resolution